These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2645851)

  • 1. Screening for hepatitis infectivity among blood donors. A model for blood safety?
    Dodd RY
    Arch Pathol Lab Med; 1989 Mar; 113(3):227-31. PubMed ID: 2645851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 3. Posttransfusion hepatitis: clinical features, risk and donor testing.
    Alter HJ
    Prog Clin Biol Res; 1985; 182():47-61. PubMed ID: 3929262
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis after the transfusion of frozen red cells and washed red cells.
    Haugen RK
    N Engl J Med; 1979 Aug; 301(8):393-5. PubMed ID: 460339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransfusion hepatitis: a persistent problem.
    Ramirez AM; Woodfield DG
    N Z Med J; 1987 Oct; 100(834):649-51. PubMed ID: 3132660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
    Kline WE
    Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy control of HB blood donor screening.
    Fiedler H
    Haematologia (Budap); 1983; 16(1-4):99-104. PubMed ID: 6679491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proper donor screening--a good prevention of transfusion transmitted AIDS and hepatitis.
    Chatterjee K
    J Acad Hosp Adm; 1994 Jul; 6(2):49-52. PubMed ID: 10537998
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G; Seed CR; Wang F; Nie D; Farrugia A
    Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor screening and epidemiology.
    Dodd RY
    Prog Clin Biol Res; 1985; 182():389-405. PubMed ID: 2994108
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Post-transfusion hepatitis in the Zürich region].
    Frey-Wettstein M; Böhlen-Bodmer A; Bütler R
    Schweiz Med Wochenschr; 1986 Sep; 116(36):1216-21. PubMed ID: 3094143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of viral hepatitis: transfusion transmitted disease and the hepatitis B vaccine.
    Holland PV
    Prog Clin Biol Res; 1983; 143():357-67. PubMed ID: 6322200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.